Global Duchenne Muscular Dystrophy Market Survey and Trend Research 2018

September 2018 | 76 pages | ID: G73D1DD4EECEN
99Strategy

Abstracts

Summary

Duchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys' respiratory and cardiac muscles are also affected and for most boys, respiratory and cardiac failure are major causes of death, often prevalent by the age of 20.

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (PTC Therapeutics, Sarepta Therapeutics, Bristol-Myers Squibb, ITALFARMACO, Daiichi Sankyo, Daiichi Sankyo, Solid Biosciences, Summit Therapeutics, FibroGen, NS Pharma, Pfizer, ReveraGen BioPharma, Wave Life, Genethon, Santhera Pharmaceuticals etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Duchenne Muscular Dystrophy Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 DUCHENNE MUSCULAR DYSTROPHY MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 PTC Therapeutics (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Sarepta Therapeutics (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Bristol-Myers Squibb (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 ITALFARMACO (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Daiichi Sankyo (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Daiichi Sankyo (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Solid Biosciences (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Summit Therapeutics (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 FibroGen (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 NS Pharma (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Pfizer (Company Overview, Sales Data etc.)
4.12 ReveraGen BioPharma (Company Overview, Sales Data etc.)
4.13 Wave Life (Company Overview, Sales Data etc.)
4.14 Genethon (Company Overview, Sales Data etc.)
4.15 Santhera Pharmaceuticals (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Duchenne Muscular Dystrophy Market 2012-2017, by Type, in USD Million
Table Global Duchenne Muscular Dystrophy Market 2012-2017, by Type, in Volume
Table Global Duchenne Muscular Dystrophy Market Forecast 2018-2023, by Type, in USD Million
Table Global Duchenne Muscular Dystrophy Market Forecast 2018-2023, by Type, in Volume
Table PTC Therapeutics Overview List
Table Duchenne Muscular Dystrophy Business Operation of PTC Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sarepta Therapeutics Overview List
Table Duchenne Muscular Dystrophy Business Operation of Sarepta Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Overview List
Table Duchenne Muscular Dystrophy Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table ITALFARMACO Overview List
Table Duchenne Muscular Dystrophy Business Operation of ITALFARMACO (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daiichi Sankyo Overview List
Table Duchenne Muscular Dystrophy Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daiichi Sankyo Overview List
Table Duchenne Muscular Dystrophy Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Solid Biosciences Overview List
Table Duchenne Muscular Dystrophy Business Operation of Solid Biosciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Summit Therapeutics Overview List
Table Duchenne Muscular Dystrophy Business Operation of Summit Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table FibroGen Overview List
Table Duchenne Muscular Dystrophy Business Operation of FibroGen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table NS Pharma Overview List
Table Duchenne Muscular Dystrophy Business Operation of NS Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Duchenne Muscular Dystrophy Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table ReveraGen BioPharma Overview List
Table Duchenne Muscular Dystrophy Business Operation of ReveraGen BioPharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Wave Life Overview List
Table Duchenne Muscular Dystrophy Business Operation of Wave Life (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Genethon Overview List
Table Duchenne Muscular Dystrophy Business Operation of Genethon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Santhera Pharmaceuticals Overview List
Table Duchenne Muscular Dystrophy Business Operation of Santhera Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Duchenne Muscular Dystrophy Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Duchenne Muscular Dystrophy Sales Revenue Share, by Companies, in USD Million
Table Global Duchenne Muscular Dystrophy Sales Volume 2012-2017, by Companies, in Volume
Table Global Duchenne Muscular Dystrophy Sales Revenue Share, by Companies in 2017, in Volume
Table Duchenne Muscular Dystrophy Demand 2012-2017, by Application, in USD Million
Table Duchenne Muscular Dystrophy Demand 2012-2017, by Application, in Volume
Table Duchenne Muscular Dystrophy Demand Forecast 2018-2023, by Application, in USD Million
Table Duchenne Muscular Dystrophy Demand Forecast 2018-2023, by Application, in Volume
Table Global Duchenne Muscular Dystrophy Market 2012-2017, by Region, in USD Million
Table Global Duchenne Muscular Dystrophy Market 2012-2017, by Region, in Volume
Table Duchenne Muscular Dystrophy Market Forecast 2018-2023, by Region, in USD Million
Table Duchenne Muscular Dystrophy Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure Duchenne Muscular Dystrophy Industry Chain Structure
Figure Global Duchenne Muscular Dystrophy Market Growth 2012-2017, by Type, in USD Million
Figure Global Duchenne Muscular Dystrophy Market Growth 2012-2017, by Type, in Volume
Figure Global Duchenne Muscular Dystrophy Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Duchenne Muscular Dystrophy Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region